Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma.

PubWeight™: 1.62‹?› | Rank: Top 4%

🔗 View Article (PMID 15376182)

Published in Br J Surg on October 01, 2004

Authors

R T P Poon1, J W Y Ho, C S W Tong, C Lau, I O L Ng, S-T Fan

Author Affiliations

1: Centre for the Study of Liver Disease, and The University of Hong Kong, Hong Kong, China.

Articles citing this

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res (2008) 4.35

Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial. J Clin Oncol (2014) 2.86

HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol (2011) 2.10

Cancer gene discovery in hepatocellular carcinoma. J Hepatol (2010) 1.68

Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. J Clin Oncol (2011) 1.43

Diagnosis of hepatocellular carcinoma. World J Gastroenterol (2009) 1.39

Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis. Br J Cancer (2009) 1.38

Emerging signaling pathways in hepatocellular carcinoma. Liver Cancer (2012) 1.32

V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials. Cancer (2010) 1.20

Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies. Biomed Res Int (2014) 1.15

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials. World J Gastroenterol (2014) 1.04

The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. PLoS One (2012) 1.03

Current approach in the treatment of hepatocellular carcinoma. World J Gastrointest Oncol (2010) 1.01

Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study. Clin Exp Metastasis (2009) 1.01

Clinical biomarkers of angiogenesis inhibition. Cancer Metastasis Rev (2008) 0.98

Sorafenib for the treatment of unresectable hepatocellular carcinoma. Biologics (2008) 0.95

Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma. N Am J Med Sci (2011) 0.94

Hepatocellular carcinoma: Review of disease and tumor biomarkers. World J Hepatol (2016) 0.94

Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma. Liver Transpl (2011) 0.90

Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study. Int Orthop (2012) 0.89

Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study. BMC Cancer (2012) 0.89

New agents on the horizon in hepatocellular carcinoma. Ther Adv Med Oncol (2013) 0.88

Exploiting novel molecular targets in gastrointestinal cancers. World J Gastroenterol (2007) 0.88

The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control. Int J Hepatol (2012) 0.88

Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy. Biomark Res (2013) 0.87

Systemic therapy of hepatocellular carcinoma: current status and future perspectives. World J Gastroenterol (2014) 0.86

Peeling off the hidden genetic heterogeneities of cancers based on disease-relevant functional modules. Mol Med (2006) 0.86

Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Chin J Cancer Res (2012) 0.86

Suppression of angiogenesis and tumor growth in vitro and in vivo using an anti-angiopoietin-2 single-chain antibody. Exp Ther Med (2014) 0.85

Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma. Biomark Cancer (2016) 0.85

DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker. World J Gastroenterol (2014) 0.85

High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection. J Cancer Res Clin Oncol (2009) 0.84

Surgical strategy for liver cancers in the era of effective chemotherapy. Liver Cancer (2013) 0.84

AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma. Oncotarget (2014) 0.84

Dual action of a selective cyclooxygenase-2 inhibitor on vascular endothelial growth factor expression in human hepatocellular carcinoma cells: novel involvement of discoidin domain receptor 2. J Cancer Res Clin Oncol (2011) 0.83

Targeted therapies in the treatment of advanced hepatocellular carcinoma. Clin Med Insights Oncol (2013) 0.83

Evolving therapies in the treatment of hepatocellular carcinoma. Biologics (2008) 0.83

Interaction of the hepatitis B spliced protein with cathepsin B promotes hepatoma cell migration and invasion. J Virol (2012) 0.83

Clinical implications of angiogenesis in cancers. Vasc Health Risk Manag (2006) 0.83

Aptamer-based Sandwich Assay and its Clinical Outlooks for Detecting Lipocalin-2 in Hepatocellular Carcinoma (HCC). Sci Rep (2015) 0.83

Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma. Oncotarget (2016) 0.82

Targeted therapy in hepatocellular carcinoma. Int J Hepatol (2011) 0.82

Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies. PLoS One (2011) 0.82

Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis. World J Hepatol (2009) 0.81

Anti-angiogenesis in hepatocellular carcinoma treatment: current evidence and future perspectives. World J Gastroenterol (2011) 0.80

Inflammatory response of endothelial cells to hepatitis C virus recombinant envelope glycoprotein 2 protein exposure. Mem Inst Oswaldo Cruz (2014) 0.80

Fractal analysis of contrast-enhanced CT images to predict survival of patients with hepatocellular carcinoma treated with sunitinib. Dig Dis Sci (2014) 0.80

Circulating angiopoietin and Tie-2 levels in systemic sclerosis. Rheumatol Int (2012) 0.80

Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell. PLoS One (2014) 0.80

Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety. Cancer Manag Res (2013) 0.80

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma. J Gastroenterol (2016) 0.79

Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus. Am J Ophthalmol (2009) 0.79

Systemic therapy in hepatocellular carcinoma. Clin Liver Dis (2011) 0.78

Increased vascular endothelial growth factor transcription in residual hepatocellular carcinoma after open versus laparoscopic hepatectomy in a small animal model. Surg Endosc (2009) 0.77

Expression of vascular endothelial growth factor in Ewing's sarcoma. Int Orthop (2012) 0.76

Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma. Oncol Lett (2017) 0.75

Association of VEGFA polymorphisms with susceptibility and clinical outcome of hepatocellular carcinoma in a Chinese Han population. Oncotarget (2017) 0.75

Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy. Int J Mol Sci (2017) 0.75

Serum vascular endothelial growth factor level in patients with hepatocellular carcinoma undergoing liver transplantation: experience of a single Western center. Int J Organ Transplant Med (2012) 0.75

A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma. Drugs R D (2017) 0.75

Tumor reductive therapies and antitumor immunity. Oncotarget (2017) 0.75

Synergistic Anticancer Activities of Natural Substances in Human Hepatocellular Carcinoma. Diseases (2015) 0.75

Articles by these authors

(truncated to the top 100)

Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med (2000) 3.32

Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics (1999) 2.69

Effects of the intermittent Pringle manoeuvre on hepatic gene expression and ultrastructure in a randomized clinical study. Br J Surg (2003) 2.19

Feeding strategies for premature infants: randomized trial of gastrointestinal priming and tube-feeding method. Pediatrics (1999) 2.18

Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg (2003) 1.88

Developmental exposure to polychlorinated biphenyls (Aroclor 1254) reduces circulating thyroid hormone concentrations and causes hearing deficits in rats. Toxicol Appl Pharmacol (1995) 1.70

Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial. Gut (2003) 1.66

Effect of an oral stimulation program on sucking skill maturation of preterm infants. Dev Med Child Neurol (2005) 1.59

Breastmilk cultures and infection in extremely premature infants. J Perinatol (2011) 1.55

Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg (2001) 1.52

Maturation of oral feeding skills in preterm infants. Acta Paediatr (2007) 1.52

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene (2001) 1.41

Rheumatoid arthritis: fish oil? Or snake oil? Br J Rheumatol (1991) 1.39

Cholestatic jaundice caused by sequential carbimazole and propylthiouracil treatment for thyrotoxicosis. Hong Kong Med J (2003) 1.38

Early feeding, antenatal glucocorticoids, and human milk decrease intestinal permeability in preterm infants. Pediatr Res (1998) 1.38

Platelet glycoprotein IIb. Chromosomal localization and tissue expression. J Clin Invest (1987) 1.31

The Dietary Quality Score: validation and association with cardiovascular risk factors: the Inter99 study. Eur J Clin Nutr (2006) 1.29

Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma. Br J Cancer (2006) 1.29

The clinical diagnosis of Alzheimer's disease. Arch Neurol (1987) 1.26

Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart (2005) 1.17

A review of antimycobacterial natural products. Phytother Res (2000) 1.17

Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma. Am J Surg (2001) 1.15

Association of BANK1 and TNFSF4 with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun (2009) 1.15

Relative validity of a food frequency questionnaire used in the Inter99 study. Eur J Clin Nutr (2007) 1.14

General practitioners' use of non-steroidal anti-inflammatory drugs in Tayside and Fife regions. J R Soc Med (1992) 1.10

Vascular risk factors and leuko-araiosis. Arch Neurol (1987) 1.09

Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine (1996) 1.09

Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch Neurol (1987) 1.07

SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma. J Pathol (2006) 1.07

Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther (2006) 1.07

Association of obesity and insulin resistance with asthma and aeroallergen sensitization. Allergy (2008) 1.06

Prolonged function of macrophage, von Willebrand factor-deficient porcine pulmonary xenografts. Am J Transplant (2006) 1.03

The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence. Br J Cancer (2007) 1.02

A survey of attitudes to Traditional Chinese Medicine in Hong Kong pharmacy students. Complement Ther Med (2004) 1.02

The use of human milk and breastfeeding in premature infants. Clin Perinatol (1999) 1.01

Surgical treatment of pancreatic insulinomas in the era of laparoscopy. Surg Endosc (2004) 1.01

Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch Neurol (1987) 1.00

PIN1 expression contributes to hepatic carcinogenesis. J Pathol (2006) 1.00

Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model. Gut (2002) 1.00

Proteolytic and chemical modification of colicin E3 activity. Biochemistry (1976) 1.00

Perforated appendicitis is not a contraindication to laparoscopy. Am Surg (1999) 0.99

Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial. Aliment Pharmacol Ther (2004) 0.98

Association of CD247 with systemic lupus erythematosus in Asian populations. Lupus (2011) 0.98

Non-invasive image acquisition and advanced processing in optical bioimaging. Comput Med Imaging Graph (1998) 0.96

Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer. Oncogene (2011) 0.96

Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br J Cancer (2013) 0.96

Behavior of colicins E1, E2, and E3 attached to sephadex beads. Biochemistry (1976) 0.95

Cardiac pacing following surgery for acquired heart disease. J Card Surg (1997) 0.94

Expression of sucrase-isomaltase mRNA along the villus-crypt axis in the rat small intestine. Cell Mol Biol (1992) 0.94

Validation of POSSUM scoring systems for audit of major hepatectomy. Br J Surg (2004) 0.93

A gradient in expression of the Escherichia coli heat-stable enterotoxin receptor exists along the villus-to-crypt axis of rat small intestine. Biochem Biophys Res Commun (1992) 0.92

Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies. Clin Exp Immunol (1982) 0.91

Outcome of emergency ERCP for acute cholangitis in patients 90 years of age and older. Aliment Pharmacol Ther (2004) 0.91

Ornithine decarboxylase in developing rat heart and brain: role of sympathetic development for responses to autonomic stimulants and the effects of reserpine on maturation. J Pharmacol Exp Ther (1977) 0.90

Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma. Oncogene (2012) 0.90

Traumatic aneurysm of the temporal artery: a report of two cases. Can J Surg (1969) 0.89

Identification of a GA-rich sequence as a protein-binding site in the 3'-untranslated region of chicken elastin mRNA with a potential role in the developmental regulation of elastin mRNA stability. J Biol Chem (2000) 0.88

Accelerated development of rat sympathetic neurotransmission caused by neonatal triiodothyronine administration. J Pharmacol Exp Ther (1979) 0.86

Maturation of sympathetic neurotransmission in the rat heart. VIII. Slowed development of noradrenergic synapses resulting from hypothyroidism. J Pharmacol Exp Ther (1982) 0.86

Early feeding, feeding tolerance, and lactase activity in preterm infants. J Pediatr (1998) 0.86

Survey of cardiac pacing in Canada (1993). Can J Cardiol (1996) 0.86

Development of cholinergic neurons in rat brain regions: dose-dependent effects of propylthiouracil-induced hypothyroidism. Neurotoxicol Teratol (1999) 0.85

Regulation of rat heart ornithine decarboxylase: change in affinity for ornithine evoked by neuronal, hormonal, and ontogenetic stimuli. Mol Pharmacol (1979) 0.85

Efficacy of a pre-S containing vaccine in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. Am J Transplant (2007) 0.85

The electroencephalogram in Alzheimer-type dementia. A sequential study correlating the electroencephalogram with psychometric and quantitative pathologic data. Arch Neurol (1987) 0.85

Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract. J Gastroenterol Hepatol (2000) 0.84

Prevalence and predictors of premature discontinuation of dual antiplatelet therapy after drug-eluting stent implantation: importance of social factors in Asian patients. Intern Med J (2009) 0.84

Effects of O 2 -CO 2 changes on hypothalamoypophyseal-adrenocortical activation. Am J Physiol (1971) 0.83

The preterm piglet - a model in the study of oesophageal development in preterm neonates. Acta Paediatr (2009) 0.83

Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia-reperfusion injury in humans. J Thromb Haemost (2011) 0.83

Adolescent alcohol exposure alters the rat adult hypothalamic-pituitary-adrenal axis responsiveness in a sex-specific manner. Neuroscience (2013) 0.83

Lack of evidence for intergenerational reproductive effects due to prenatal and postnatal undernutrition in the female CD-1 mouse. Reprod Toxicol (2003) 0.83

Implementation of a pharmacist-driven pain management consultation service for hospitalised adults with a history of substance abuse. Int J Clin Pract (2013) 0.83

Liver transplantation for hepatocellular carcinoma. Br J Surg (2004) 0.83

Laparoscopic resection of a pancreatic polypeptidoma with a solitary liver metastasis. Surg Endosc (2004) 0.82

Effect of fluorescein on the tear stability of Hong Kong-Chinese. Optom Vis Sci (1996) 0.82

Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre. Br J Surg (2004) 0.82

Improving access to intestinal stem cells as a step toward intestinal gene transfer. Hum Gene Ther (1994) 0.82

Two missense variants in UHRF1BP1 are independently associated with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun (2011) 0.82

Rat brain synaptic vesicles: uptake specificities of [3H]norepinephrine and [3H]serotonin in preparations from whole brain and brain regions. J Neurochem (1978) 0.82

Characterization of the mammalian toxicity of the crystal polypeptides of Bacillus thuringiensis subsp. israelensis. Fundam Appl Toxicol (1989) 0.82

Conditions influencing formation of 16:0/16:0 molecular species in membrane phospholipids of Escherichia coli. J Biol Chem (1983) 0.81

Retracted Fat-derived hormone adiponectin combined with FTY720 significantly improves small-for-size fatty liver graft survival. Am J Transplant (2006) 0.81

Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: a mathematical construct. Toxicol Sci (2001) 0.81

Impaired release of a T-cell specific suppressor factor in rheumatoid arthritis. Clin Exp Immunol (1985) 0.81

Maturation of sympathetic neurotransmission in the rat heart. VII. Suppression of sympathetic responses by dexamethasone. J Pharmacol Exp Ther (1981) 0.81

Imaging features of hepatic angiomyolipomas. J Med Imaging Radiat Oncol (2008) 0.81

Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice. J Pathol (2009) 0.81

Biologically based dose-response modeling in developmental toxicology: biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat. Toxicol Appl Pharmacol (1994) 0.81

Beta-adrenergic receptor overexpression in the fetal rat: distribution, receptor subtypes, and coupling to adenylate cyclase activity via G-proteins. Toxicol Appl Pharmacol (1994) 0.81

Differential regulation of human progesterone receptor A and B form-mediated trans-activation by phosphorylation. Endocrinology (1993) 0.81

Identification of a large region of secondary structure in the 3'-untranslated region of chicken elastin mRNA with implications for the regulation of mRNA stability. J Biol Chem (1999) 0.80

Prenatal alpha-difluoromethylornithine treatment: effects on postnatal renal growth and function in the rat. Teratology (1989) 0.80

Neonatal central catecholaminergic lesions with intracisternal 6-hydroxydopamine: effects on development of presynaptic and postsynaptic components of peripheral sympathetic pathways and on the ornithine decarboxylase/polyamine system in heart, lung and kidney. J Pharmacol Exp Ther (1988) 0.80

Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2004) 0.80

Cortical sulcal development seen on sonography: relationship to gestational parameters. J Ultrasound Med (1986) 0.80

Sample preparation and high-performance liquid chromatographic analysis of deoxyribonucleoside triphosphates in individual rat embryos. Anal Biochem (1998) 0.79

Central adrenergic receptor changes in the inherited noradrenergic hyperinnervated mutant mouse tottering. Brain Res (1987) 0.79

Development of polyamine and biogenic amine systems in brains and hearts of neonatal rats given dexamethasone: role of biochemical alterations in cellular maturation for producing deficits in ontogeny of neurotransmitter levels, uptake, storage and turnover. J Pharmacol Exp Ther (1982) 0.79

Glucocorticoid receptor expression during the development of the embryonic mouse secondary palate. J Craniofac Genet Dev Biol (1994) 0.79